Results 61 to 70 of about 46,238 (244)

Isolated right ventricular Takotsubo cardiomyopathy in Guillain–Barré syndrome

open access: yesBMC Cardiovascular Disorders, 2022
Background Takotsubo cardiomyopathy can present itself in the most varied clinical forms, with extremely variable electrocardiogram anomalies and presence of comorbidities with a significant systemic commitment.
Xiaojing Song   +3 more
doaj   +1 more source

What are the vector species of the Oropouche virus?

open access: yesPest Management Science, EarlyView.
Here, we review the timeline of Oropouche virus (OROV) detection in various hematophagous Diptera, from 1955 to date, including mosquitoes and midges. All vector competence experiments also are described. The results suggest that Culicoides are the primary vectors.
Constância Flávia Junqueira Ayres   +3 more
wiley   +1 more source

Guillain-Barré syndrome with transition from hashimoto's to graves' disease: a case report

open access: yesBMC Endocrine Disorders, 2022
Background On rare occasions, there can be a transition from Hashimoto's to Graves' disease. However, there are no reported cases of transition from Hashimoto's to Graves' disease triggered by the onset of Guillain-Barré syndrome.
Mari Asano, Tsuneaki Kenzaka
doaj   +1 more source

Incidence of Guillain-Barre syndrome among patients with Campylobacter infection: A general practice research database study [PDF]

open access: yes, 2006
The association between Campylobacter infection and subsequent Guillain-Barre syndrome (GBS) has been well documented. To date, however, there exists no direct estimate of the incidence of GBS among patients with Campylobacter infection.
Hayward, A   +5 more
core  

Guillain-Barré syndrome in temporal association with influenza A vaccine [PDF]

open access: yes, 2011
OBJECTIVE: To report a case of Guillain-Barré syndrome following influenza A (H1N1) 2009 vaccine. CASE DESCRIPTION: A four-year-old boy presented right thigh pain and ascending muscular weakness 15 days after the second dose of influenza A (H1N1) 2009 ...
Ferrarini, Maria Aparecida G   +5 more
core   +3 more sources

IMpower010: 5‐Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB–IIIA Non‐Small Cell Lung Cancer

open access: yesCancer Science, EarlyView.
The global Phase 3 IMpower010 study (NCT02486718) evaluated atezolizumab versus best supportive care (BSC) after complete resection and adjuvant platinum‐based chemotherapy in patients with stage IB–IIIA non‐small cell lung cancer (NSCLC). Here, we report updated efficacy and safety results from the disease‐free survival (DFS) final and overall ...
Morihito Okada   +9 more
wiley   +1 more source

Perioperative Nivolumab in Resectable Non‐Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T

open access: yesCancer Science, EarlyView.
ABSTRACT In the randomized phase III CheckMate 77T study, perioperative nivolumab showed statistically significant and clinically meaningful improvement in event‐free survival (EFS) vs. placebo in patients with resectable, non‐metastatic non‐small cell lung cancer (NSCLC).
Fumihiro Tanaka   +17 more
wiley   +1 more source

A rapid onset of Guillain–Barre syndrome following spinal anesthesia for knee arthroscopy: a case report

open access: yesJournal of Medical Case Reports
Background Guillain–Barré syndrome, a rare autoimmune polyneuropathy, typically follows infections and rarely surgical procedures. Post-surgical Guillain–Barré syndrome is an uncommon subset with significant clinical implications.
Amin Ahmed Kapadia   +4 more
doaj   +1 more source

Guillain-Barré

open access: yesJournal of Education and Teaching in Emergency Medicine, 2018
Audience: This scenario was developed to educate emergency medicine residents on the diagnosis and management of Guillain-Barré syndrome in the emergency department.
Jennifer Yee, DO   +2 more
doaj   +1 more source

High doses of immunoglobulin g in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome [PDF]

open access: yesVojnosanitetski Pregled, 2006
Background/Aim. High doses of immunoglobulin G (IVIG) have been recognized as a very important therapeutic modality in the treatment of neurological diseases.
Lavrnić Dragana   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy